Identification of Potential Key Genes and Pathways in Enzalutamide-Resistant Prostate Cancer Cell Lines: A Bioinformatics Analysis with Data from the Gene Expression Omnibus (GEO) Database.

Enzalutamide (ENZ) has been approved for the treatment of advanced prostate cancer (PCa), but some patients develop ENZ resistance initially or after long-term administration. Although a few key genes have been discovered by previous efforts, the complete mechanisms of ENZ resistance remain unsolved...

Full description

Bibliographic Details

Published in:	BioMed Research International pp. 1 - 13
Main Authors:	Zheng, Long, Dou, Xiaojie, Ma, Xiaodong, Qu, Wei, Tang, Xiaoshuang
Format:	pictorial research tables/charts Journal Article
Published:	Wiley-Blackwell 7/17/2020
Online Access:	View this record in EBSCOhost